Healsun Biopharm Funding: $27M Raised, Series C (2023)

Healsun Biopharm is based in Hangzhou, Zhejiang, China. It has raised $27M in total funding. Latest round: Series C.

Healsun Biopharm funding overview

Healsun Biopharm is based in Hangzhou, Zhejiang, China. Healsun Biopharm has raised $27M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in October 2023. The round record for Healsun Biopharm runs through 2023; nothing later has been disclosed. Investors on record include Shenzhen Kangzhe Pharmaceutical Co., Ltd., Hangzhou Oriental Jiafu Asset Management Co., Ltd., China Medical System Holdings Limited. 3 distinct backers are named across the disclosed rounds.

Healsun Biopharm at a glance

Total raised
$27M
Latest round
Series C
Latest round date
October 2023
Headquarters
Hangzhou, Zhejiang, China
Notable investors
Shenzhen Kangzhe Pharmaceutical Co., Ltd., Hangzhou Oriental Jiafu Asset Management Co., Ltd., China Medical System Holdings Limited

Frequently asked about Healsun Biopharm funding

How much has Healsun Biopharm raised?
Healsun Biopharm has raised $27M in total disclosed funding across the rounds on record.
Who has invested in Healsun Biopharm?
Shenzhen Kangzhe Pharmaceutical Co., Ltd., Hangzhou Oriental Jiafu Asset Management Co., Ltd., China Medical System Holdings Limited are named among the investors backing Healsun Biopharm.
What was the latest Healsun Biopharm funding round?
The most recent disclosed round is a Series C, announced in October 2023.
Where is Healsun Biopharm based?
Healsun Biopharm is based in Hangzhou, Zhejiang, China.
When did Healsun Biopharm last raise?
The last disclosed Healsun Biopharm round closed in October 2023 at Series C.

Healsun Biopharm totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hangzhou below to benchmark round size and investor mix.

Healsun Biopharm funding history

1 disclosed round on record.

  1. October 2023 — Series C. $27.5M.

Companies related to Healsun Biopharm (18)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades